Substance use and medication nonadherence are major, intertwined drivers of preventable illness and early death worldwide, particularly in settings where access to healthcare and essential services is inconsistent. While the seed text references “APC” not “seeing” someone and urges finding food, the underlying clinical topic most consistent with health risk language is medication nonadherence and treatment interruption in resource-constrained environments. When people cannot reliably obtain medicines or basic needs such as food, adherence typically worsens because treatment regimens become harder to sustain, side effects feel intolerable, and follow-up care becomes unlikely.
Medication nonadherence includes not taking drugs as prescribed, taking them irregularly, stopping prematurely, or failing to fill prescriptions. It may be intentional (beliefs about efficacy, fear of adverse effects, religious or cultural concerns, stigma) or unintentional (cost, transportation barriers, health system delays, forgetfulness, low health literacy, chaotic living conditions, or limited medication supply). In clinical terms, nonadherence can lead to under-treatment, disease progression, and higher rates of hospitalization and mortality.
Mechanistically, adherence failure undermines pharmacodynamics and pharmacokinetics. Many therapies require sustained therapeutic exposure—such as antiretrovirals for HIV, antiepileptics for seizure prevention, immunosuppressants after organ transplant, and disease-modifying agents for autoimmune disease. Interrupted dosing can allow viral replication, immune rebound, inflammatory flare-ups, or seizure susceptibility, depending on the condition. Even for antibiotics, incomplete courses can contribute to persistent infection and selecting for antimicrobial resistance. For chronic cardiometabolic diseases, inconsistent dosing can destabilize blood pressure, glucose control, and lipid management, increasing microvascular and macrovascular complications.
Food insecurity can directly worsen adherence. Starvation or irregular meals alters drug absorption and metabolism. Some medications are intended to be taken with food to reduce gastrointestinal irritation or to improve absorption, so skipping meals can increase adverse effects and prompt stopping. Additionally, hunger increases cognitive load and reduces the ability to remember complex regimens. Economic strain may force trade-offs between buying food and buying medicines. This creates a predictable cycle: poor nutrition worsens symptoms and side effects; symptoms drive discontinuation; discontinuation leads to disease worsening; worsening disease further limits ability to earn income.
Psychologically, resource scarcity can produce stress, hopelessness, and avoidance behaviors that further degrade adherence. Anxiety and depressive symptoms can reduce motivation and self-efficacy, impairing planning and follow-through. Cognitive limitations from sleep deprivation or malnutrition may reduce comprehension of instructions and the ability to manage timing (e.g., twice-daily dosing). Stigma around certain treatments—such as medications for mental health, HIV, or opioid dependence—can also intensify avoidance when healthcare access is unreliable.
Clinically, nonadherence is often detected indirectly. Providers may notice rising biomarkers, increasing symptom frequency, missed appointments, or pharmacy refill gaps. A structured approach includes assessing whether the patient can obtain the medicine, understand the regimen, and tolerate side effects. Tools such as the Morisky Medication Adherence Scale, pill counts, pharmacy claims, and electronic monitoring may help, but contextual interviews are essential to identify barriers.
Interventions should be multilevel. At the patient level, clinicians can simplify regimens (once-daily dosing, fixed-dose combinations), use clear language and visual aids, and provide side-effect counseling with practical strategies (e.g., taking with food when appropriate, managing nausea). Shared decision-making improves buy-in, while motivational interviewing can address ambivalence. At the system level, improving supply reliability, reducing cost through subsidies, expanding community drug distribution, and strengthening appointment reminders can substantially improve adherence. Integration with nutrition support—food assistance, counseling on affordable meal planning, and screening for food insecurity—can break the adherence–malnutrition cycle.
For high-risk populations, follow-up should be proactive. After starting therapy or during regimen changes, early contact within days can prevent discontinuation driven by initial adverse effects. For chronic diseases, ongoing adherence coaching, peer support, and telemedicine check-ins may reduce attrition. In emergency scenarios, clinicians can consider short bridging supplies or alternative formulations when standard medicines are temporarily unavailable.
In summary, medication nonadherence in resource-limited settings is not merely a behavioral failure; it is a predictable outcome of medication access constraints, food insecurity, stress, stigma, and health system friction. The most effective strategies combine accurate identification of barriers with regimen simplification, counseling, supply and cost improvements, and targeted nutrition support. Addressing “can’t access care or food” alongside “how to take medication” is essential to prevent deterioration, complications, and resistance. Source: Oluadebambo (X/Twitter post referencing “APC no dey see you” and advice to “go find food eat?”).
omo iya seyi..: @Onsogbu Better go find food eat? APC no dey see you o. #breaking
— @oluadebambo May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
